Drawing for HERON COMMITMENT PROGRAM

USPTO serial 87667703

HERON COMMITMENT PROGRAM

Reviewed by CopyMark Law Group

Reg. 5515599Status 702Registered
Filing date
Status date
Registration date
Jul 10, 2018
Examiner
SCHWARZ, KATHLEEN MICHELLE HUD
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with HERON COMMITMENT PROGRAM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Beth M. Goldman

Beth M. Goldman ORRICK, HERRINGTON & SUTCLIFFE LLP2050 Main Street, Suite 1100IP Prosecution DepartmentIRVINE, CA 92614-8255

Goods and services

ClassDescriptionStatusFirst use
035Business administration of patient and pharmacy reimbursement programs and services; business assistance in patient enrollment for patient and pharmaceutical reimbursement programsACTIVE—
036Financial administration of health reimbursement arrangements; financial administration of patient reimbursement programs; Financial services, namely, assistance in collecting from pharmaceutical reimbursement programs for patients, pharmacists, and physicians; providing a database featuring financial information about patient reimbursement and insurance coverage for pharmaceuticalsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 4, 2024NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Jun 4, 2024C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jun 4, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 28, 2023E815TEAS SECTION 8 & 15 RECEIVED—
Aug 16, 2023ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Jul 10, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jul 10, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 6, 2018SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jun 5, 2018CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
May 17, 2018SUPCSTATEMENT OF USE PROCESSING COMPLETE—
May 17, 2018AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 25, 2018IUAFUSE AMENDMENT FILED—
Apr 25, 2018EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Apr 17, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 20, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 20, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 31, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 16, 2018ALIEASSIGNED TO LIE—
Jan 5, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 4, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Jan 4, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 4, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 4, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 2, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Jan 2, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 2, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 2, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 29, 2017GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Dec 29, 2017GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Dec 29, 2017CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Dec 18, 2017DOCKASSIGNED TO EXAMINER—
Nov 9, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 4, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance